Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
<p>Physicians employed in operating and emergency rooms have utilized opioid antagonist for almost half a century for the treatment of opioid overdose. The prototype antagonist remainsnaloxone hydrochloride, which actually received FDA approval back in 1971. Why after so many years on the mark...
Saved in:
Main Author: | Adam M Kaye (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Anesthesiology - Peertechz Publications,
2014-08-13.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors
by: Stephen Commiskey, et al.
Published: (2005) -
Interim opioid agonist treatment for opioid addiction: a systematic review
by: Laura Samsó Jofra, et al.
Published: (2022) -
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5'-guanidinonaltrindole and the biased kappa opioid receptor agonist 6'-guanidinonaltrindole in mice
by: Alan Cowan, et al.
Published: (2021) -
Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019) -
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
by: Yuki Moriya, et al.
Published: (2023)